stock rating
Wolfe Research Upgrades Danaher to Outperform
The upgrade is based on the firm's improving growth, more reasonable valuations, and its ability to deploy capital.
UBS Initiates Coverage of Veracyte With Buy Rating
Analysts noted that they envision "durable growth" in Veracyte's Afirma and Decipher Prostate tests and "long-term growth potential" from its MRD testing business.
Barclays Upgrades Revvity to Overweight
The firm's analysts wrote that they see stability in Revvity's diagnostics business and growth above peers in its life sciences and reagents business.
JP Morgan Initiates Coverage of Hologic With Neutral Rating
The investment bank said in a note to investors that Hologic's strong credit statistics and ratings are priced in, and investors are waiting for a return to growth and margin improvements.
Craig-Hallum Initiates Coverage of GeneDx With Buy Rating
The investment bank cited the firm's strong growth in its whole-exome and whole-genome sequencing businesses and a clear path to profitability.